Articles We’d Like to Commission
ChinaTalk is looking for new contributors to pitch deeply reported and analytically sharp pieces that go beyond headline narratives. Below is our wish list for H1 2026 that hopefully inspires you to to send us a pitch! It can either be directly related to some of the ideas below or just something you think we’d […]
Assortment of FREE Kindle eBooks
Thumb Score: 0 Please remember to always verify the PRICE says “$0.00” before clicking “Buy Now,” as Prices for eBooks can change. The GLP-1 High Protein Cookbook for Weight Loss – $0 https://www.amazon.com/dp/B0FR9BFQ8J German Christmas Cookies – $0 https://www.amazon.com/dp/B0FXRQR8MW What the Hell Is Happening to Me?: The Straight-Talk Guide to Perimenopause & Menopause Symptoms and […]
Woman, 32, Credits GLP-1 with Helping Her Stop Eating Noodle Sandwiches and ‘a Block of Chocolate’ a Day
Lynsey Macfadyen used to turn to food for comfort, until weight-loss medication helped her reshape her relationship with food
Ozempic boom collides with America’s eating habits as restaurants shrink portions
Once known for bottomless breadsticks and supersized meals, American chain restaurants are increasingly rethinking their portion sizes. As GLP-1 weight-loss medications like Ozempic, Wegovy and Zepbound go mainstream, restaurants are responding to customers with smaller appetites — and a growing appetite for protein-packed meals. “People on GLP-1s are prioritizing protein because it’s the macronutrient that […]
Body “positivity” ad shows fat man complaining that you are shaming him, then you find out who’s behind the campaign
Watch Louder with Crowder every weekday at 11:00 AM Eastern, only on Rumble Premium! WATCH: This Eli Lilly weight loss ad is getting attention. Does it hit the mark? Thoughts? ⬇️ 🇺🇸 pic.twitter.com/VciEAuq9r7— Tony Lane 🇺🇸 (@TonyLaneNV) January 26, 2026 Yesterday, while most of America was bored watching the AFC Championship game and mortified that […]
FuturHealth Expands Its Suite of Wellness Solutions With the Addition of the Wegovy® Pill
The first FDA-approved oral GLP-1 pill is now available to new and existing FuturHealth members SAN DIEGO, Jan. 26, 2026 /PRNewswire/ — FuturHealth, a leader in personalized health and weight-loss solutions, today announced that it is expanding its suite of care options to include the…
STAT+: Launch of Wegovy pill looks to be going strong so far
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today, we see a new synthetic biology startup, backed by Frances Arnold and Bob Langer. Plus, it’s still early, but Novo Nordisk already appears to be having a robust rollout of the Wegovy pill. […]
IJMS, Vol. 27, Pages 1218: Plasma GLP-1 (Glucagon-like Peptide-1) Depletion Is Correlated with Dysregulation of Adipocytokine in Type 2 Diabetic Patients With or Without Metabolic-Associated Fatty Liver Disease (MAFLD): A Cross-Sectional Study Related to Gender-Sex Disparities
IJMS, Vol. 27, Pages 1218: Plasma GLP-1 (Glucagon-like Peptide-1) Depletion Is Correlated with Dysregulation of Adipocytokine in Type 2 Diabetic Patients With or Without Metabolic-Associated Fatty Liver Disease (MAFLD): A Cross-Sectional Study Related to Gender-Sex Disparities International Journal of Molecular Sciences doi: 10.3390/ijms27031218 Authors: Zoubiri Houda Saiah Wassila Otmane Amel Saidi Hamza Makrelouf Mohamed Aitabderrhmane […]
15 Celebs Shelling Out for GLP-1s
Celebrities have a way of shaping trends, and lately, GLP-1 drugs have landed squarely in their spotlight. Some stars openly talk about using them, others partner with brands, and suddenly what was once a niche medical topic is everywhere on social media. From candid interviews to Instagram posts, these figures are influencing how we think […]
GLP‐1RAs versus metformin and Parkinson’s risk in type 2 diabetes
Abstract Background Parkinson’s disease (PD) is an increasingly prevalent neurodegenerative condition, particularly among individuals with type 2 diabetes mellitus (T2DM). While prior studies have suggested that GLP-1 receptor agonists (GLP-1RAs) and metformin may confer neuroprotective effects, most were limited by small sample sizes, short follow-up, uncontrolled designs, or lacked direct comparisons between therapies—making their findings […]